Celularity Inc.
CELU
$2.04
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.45% | 52.06% | 138.11% | 225.94% | 182.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.45% | 52.06% | 138.11% | 225.94% | 182.02% |
| Cost of Revenue | 17.96% | 7.99% | -6.41% | 48.06% | 11.20% |
| Gross Profit | -4.46% | 90.67% | 480.77% | 887.40% | 20,190.63% |
| SG&A Expenses | 3.45% | 16.20% | 15.95% | -1.65% | -11.52% |
| Depreciation & Amortization | -29.27% | -28.34% | -20.06% | -11.99% | -3.88% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.21% | 5.40% | -6.53% | -21.43% | -35.32% |
| Operating Income | -5.94% | 23.36% | 49.59% | 59.00% | 62.74% |
| Income Before Tax | 34.70% | 63.94% | 70.51% | 80.68% | -36.36% |
| Income Tax Expenses | -- | -- | -- | -23.08% | 350.00% |
| Earnings from Continuing Operations | 34.71% | 63.94% | 70.51% | 80.68% | -36.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.71% | 63.94% | 70.51% | 80.68% | -36.38% |
| EBIT | -5.94% | 23.36% | 49.59% | 59.00% | 62.74% |
| EBITDA | -11.16% | 24.72% | 54.39% | 64.07% | 67.49% |
| EPS Basic | 45.12% | 70.05% | 76.58% | 84.65% | -20.33% |
| Normalized Basic EPS | -145.57% | 2.80% | 48.47% | 80.80% | 85.76% |
| EPS Diluted | 45.12% | 70.05% | 76.58% | 85.21% | -10.65% |
| Normalized Diluted EPS | -145.57% | 2.80% | 48.47% | 79.85% | 84.97% |
| Average Basic Shares Outstanding | 12.92% | 16.25% | 22.95% | 26.72% | 30.97% |
| Average Diluted Shares Outstanding | 12.92% | 16.25% | 22.95% | 19.60% | 21.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |